Are you familiar with hives? If not, it's a skin condition that affects millions of people worldwide. Hives are characterized by red, itchy welts or patches on the skin that can appear and disappear in a matter of hours. They may seem harmless at first glance, but they can be quite uncomfortable and even debilitating for some individuals. In this blog post, we'll explore what causes hives and delve into common allergens and irritants associated with this condition to help medical professionals better understand how to diagnose and treat their patients effectively. Let's get started!
Hives are often caused by an allergic reaction to certain substances, such as foods, medications or insect bites. However, in some cases, hives can be a symptom of an underlying condition. This means that the appearance of hives may indicate the presence of an illness or disease in the body.
One common underlying condition associated with hives is autoimmune diseases like lupus and thyroid disorders such as Hashimoto's disease. These conditions cause the immune system to attack healthy cells and tissues in the body leading to inflammation and skin rashes including hives.
Other possible underlying conditions include viral infections like hepatitis B or C, bacterial infections like streptococcus infection, parasitic infections like pinworms infestations among others. In these cases, treating the underlying condition will help alleviate hive symptoms.
Vitamin D plays an important role in the immune system, and it has been suggested that it may also have a beneficial effect on chronic hives. Some studies have shown that people with chronic hives tend to have lower levels of vitamin D compared to those without the condition.
One theory is that vitamin D helps to regulate the production of certain immune cells involved in allergic reactions, which could potentially reduce inflammation and ease symptoms of chronic hives.
However, more research is needed to determine whether supplementing with vitamin D can actually improve symptoms of chronic hives.
In addition, getting enough natural sunlight exposure is another way to boost your body's vitamin D levels. However, excessive sun exposure can trigger or worsen hives for some people, so it's important to use sun protection measures if spending time outdoors.
Hives can be a frustrating and uncomfortable condition to deal with. It's important for medical professionals to understand the common allergens and irritants that can cause hives in order to properly diagnose and treat their patients.
While certain underlying conditions may contribute to chronic hives, there is still much research needed in this area. However, vitamin D supplements have shown promise in improving symptoms for some patients.
1.
In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
4.
A prostate cancer risk prediction algorithm could help target men at highest risk
5.
A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.
1.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
2.
Bone Marrow Regeneration in Hematologic Recovery
3.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
4.
Iron Homeostasis Throughout the Female Lifespan
5.
Demystifying Lymphocytes: Everything You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation